Agreement between Turk İlaç and Russian Chromis for coronavirus drug Avifavir

Turk Pharmaceuticals, which was established within Battal Holding and started its activities in 2010, took the responsibility for the coronavirus epidemic that emerged in Wuhan, China. The company, which produces human drugs and vaccines, signed an agreement with Russian Chromis for the sale and production of the coronavirus drug Avifavir.

Turk İlaç signed a framework agreement with Chromis LLC Company for the sale and production of the drug Avifavir.

In the statement made by the company to the Public Disclosure Platform (KAP), “The sale and production of the drug named Avifavir with favipiravir active ingredient used in the treatment of coronavirus COVID -19 between Chromis LLC Company located in Russia and TURK İlaç Ve Serum Sanayi A.Ş. A framework agreement was signed in which the main commercial and legal lines were determined. statements were included.

Leave a Reply

Your email address will not be published. Required fields are marked *